{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-108417","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2026-09-17T11:18:22+00:00","discovered_at":"2026-09-17T11:20:00.791315+00:00","generated_at":"2026-09-17T11:20:07.853362+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"dividend","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Indivior declares $8.13/shr special dividend contingent on Supernus merger closing","bullets":["Special dividend of $8.13 per share; record date October 30, 2026; payment expected ~November 6, 2026.","Payment contingent on merger closing expected on or about November 2, 2026; no dividend if merger fails.","Supernus stockholders ineligible for dividend on Indivior shares received in merger.","Indivior expects majority of dividend to exceed current/accumulated earnings; treated as return of capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-108417","json":"https://secwatch.observer/filing/0001104659-26-108417.json","markdown":"https://secwatch.observer/filing/0001104659-26-108417.md","text":"https://secwatch.observer/filing/0001104659-26-108417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000110465926108417/0001104659-26-108417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000110465926108417/tm2623753d7_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-17T11:20:07.853362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}